S. Machtens
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Oncology top 10%
- Surgery top 10%
- Psychiatry and Mental health top 5%
- Co-authors
- Udo JonasChristian G. StiefMarkus A. KuczykArmin BeckerStefan ÜckertWolfram H. KnappJürgen SerthCarsten Bokemeyer
- Topics
- Prostate Cancer Treatment and Research (28 papers)Prostate Cancer Diagnosis and Treatment (16 papers)Urinary Bladder and Prostate Research (14 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
S. Machtens
87 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 99
- Pulmonary and Respiratory Medicine 627
- Molecular Biology 491
- Oncology 376
- Surgery 335
- Psychiatry and Mental health 297
Countries citing papers authored by S. Machtens
This map shows the geographic impact of S. Machtens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Machtens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Machtens more than expected).
Fields of papers citing papers by S. Machtens
This network shows the impact of papers produced by S. Machtens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Machtens. The network helps show where S. Machtens may publish in the future.
Co-authorship network of co-authors of S. Machtens
This figure shows the co-authorship network connecting the top 25 collaborators of S. Machtens. A scholar is included among the top collaborators of S. Machtens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Machtens. S. Machtens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 5 | |
| 3 | 8 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 24 | |
| 7 | 12 | |
| 8 | 121 | |
| 9 | 16 | |
| 10 | 26 | |
| 11 | 216 | |
| 12 | 3 | |
| 13 | 5 | |
| 14 | 40 | |
| 15 | 1 | |
| 16 | 23 | |
| 17 | 3 | |
| 18 | 38 | |
| 19 | 32 | |
| 20 | [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status]. | 1 |
About S. Machtens
S. Machtens is a scholar working on Urology, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 89 papers that have together received 1.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (16 papers) and Urinary Bladder and Prostate Research (14 papers). The work is most often cited by research in Urology (266 citations), Psychiatry and Mental health (297 citations) and Pulmonary and Respiratory Medicine (627 citations). S. Machtens has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Udo Jonas, Christian G. Stief, Markus A. Kuczyk, Armin Becker, Stefan Ückert, Wolfram H. Knapp, Jürgen Serth, Carsten Bokemeyer, Michael C. Truß and M.A. Kuczyk. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.